174
Participants
Start Date
September 1, 2025
Primary Completion Date
September 1, 2026
Study Completion Date
December 1, 2026
Personalized SV-guided resuscitation
Participants will receive an IV fluid bolus directly after inclusion. Next, measurement of the cardiac output change in response to the fluid bolus by the Starling SV will be used to determine fluid responsiveness. Vital parameters and fluid responsiveness will be used to guide hemodynamic resuscitation, consisting of IV fluids and/or vasopressors, during the first 3 hours.
Standard Care Resuscitation
In the control group, IV fluid and vasopressor administration will be determined at the discretion of the physician and in accordance with currently available guidelines (e.g. Sepsis Surviving Campaign).
RECRUITING
University Medical Centre Groningen, Groningen
University Medical Center Groningen
OTHER